|
|
||||||||
Ann Thorac Surg 2002;74:1139-1143
© 2002 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, University Hospital J.W. Goethe, Frankfurt am Main, Germany
Accepted for publication May 29, 2002.
* Address reprint requests to Dr Martens, Klinik für Thorax-, Herz und Thorakale Gefäßchirurgie, Klinikum der J.W. Goethe Universität, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
e-mail: martens.herz{at}gmx.de
| Abstract |
|---|
|
|
|---|
Methods. One automated distal coronary anastomosis was initially placed in each patient, the other anastomoses were created with standard running sutures. After a "flat foot"-shaped prototype was deployed in 30 patients (group I), the design of the foot was modified and deployment of the new device performed in the next 30 patients (group II).
Results. In group I, automated anastomoses were completed in 16 patients (53%) using 1.7 ± 1 additional stitches. In 26 group II patients (86%), a hemostatic anastomosis using 1.2 ± 1 additional stitches was achieved. Anastomoses were completed in 19.0 ± 3 minutes in group I and in 15.6 ± 2 minutes in group II.
Conclusions. We have shown the feasability of coronary anastomoses using the Heartflo device. The modified version improved tissue capture, resulting in a higher rate of completed anastomoses. Because anastomotic time is still prolonged, an easier suture management is mandatory in the next developmental step.
| Introduction |
|---|
|
|
|---|
The Heartflo anastomotic device (Perclose/Abbott Labs, Redwood City, CA) is a micromechanical suturing device for coronary artery bypass grafting. It automates the suturing process by a simultaneous delivery of 10 interrupted sutures through the graft and the vessel wall. End-to-side anastomoses of vein grafts to coronary arteries, and side-to-side anastomoses of vein grafts or internal thoracic arteries (ITA) to coronary arteries are possible. Shennib and colleagues [3] published their early experiences in animals in 2000. Tozzi and associates [5] and our group [6] reported preliminary clinical experiences with the Heartflo suturing device. We started our first clinical trial (group I) in April 2000. Because a modification of the foot of the device had shown improved tissue capture in bench testing and animal studies, a second series was started in June 2001.
| Material and methods |
|---|
|
|
|---|
|
|
|
Coronary artery size was measured using standard probes of 1 to 2.5 mm. The target vessels were as follows: right coronary artery: group I (4 patients) and group II (5); distal branches of the right coronary artery: group I (21) and group II (11); obtuse marginal branch of the left coronary artery: group I (0) and group II (11); circumflex artery: group I (3) and group II (3); left anterior descending coronary artery: group I (2) and group II (0 patient). In 4 patients of group I, a side-to-side anastomotic device was applied, 2 patients received internal thoracic artery grafts to the left anterior descending coronary artery with this version. We discontinued its application because our initial experiences with the end-to-side device were more promising. Flow through the anastomoses was measured by application of cardioplegia through a delivery line connected to the vein graft; the pressure did not exceed 100 mm Hg. The other distal anastomoses were performed using standard running sutures (7-0 polypropylene for vein grafts, 8-0 for internal thoracic artery grafts). The same surgeon performed all interventions. The study was approved by our local ethics committee; informed consent was obtained from all patients.
| Results |
|---|
|
|
|---|
|
We had one noncardiac death in group II (a patient on chronic dialysis died 4 days after the operation). Another patient with history of several strokes showed prolonged recovery due to perioperative stroke with hemiparesis. One group I patient was reexplored for bleeding, not caused by a distal anastomosis. The clinical course during hospital stay was uneventful for all other patients, no myocardial infarction or other cardiac adverse event occurred in our study groups. Angiographies were performed on 6 patients at follow-up; all automated anastomoses were patent.
| Comment |
|---|
|
|
|---|
Nonpenetrating clips were introduced in vascular surgery in 1992 by the group of Kirsch [9] and used for coronary anastomoses in 1997 by the group of Nataf [10]. They reported clinical results in 10 patients. The anastomotic procedure took 15 minutes, the surgeon performed the eversion of the vessel wall while the assistant applied the clips. Limitations of this method were seen in calcified vessel walls. Heijmen and colleagues [11] reported the application of a one-shot anastomotic stapler on the beating heart in an animal model. Occlusion of the coronary arteries was limited to 3 minutes; the procedure was successful in 8 of 14 anastomoses with 12 clips applied circumferentially. Minimal intimal hyperplasia, more pronounced when compared with conventionally sutured anastomoses, was seen 28 days after the operation. Solem and coworkers [12] presented their results with a new device for performing quick sutureless vascular anastomoses by means of stent technology. Short-term results were encouraging, with equivalent flow through an anastomosis created in less than 3 minutes compared with a conventional anastomosis. The disadvantage of any technique using intraluminal stents is the possible impairment of long-term patency by in-stent stenosis. Gundry and coworkers [13] reported a different approach to create sutureless coronary anastomoses, using biological glue formulated from bovine albumin and glutaraldehyde. Follow-up showed intact anastomoses 1 year after the procedure. A possible disadvantage of this method is that glutaraldehyde is a toxic component.
The implication of using the same suture material (7-0 polypropylene) as in a conventional handsewn coronary anastomosis is interesting because it does not leave additional endovascular material behind. Endovascular material possibly induces intimal proliferation, as in stents [3]. Several investigators describe a better performance with interrupted suturing techniques in coronary anastomoses, leading to optimal internal configuration with minimal deformity and less narrowing of the anastomotic contour [1, 2]. The disadvantage of the interrupted suture lines created with the Heartflo device is that each pair of sutures has to be tied separately to complete the anastomosis, and suture management is time consuming with the current generation of devices.
Our clinical study has proved feasability of automated coronary anastomoses with the Heartflo device. Initially apparent mechanical problems with the "flat foot" anastomotic device (4 patients) were resolved, so that in next patients no device-related problems occurred. Use of the device in small coronary arteries was limited by the coronary artery size. The square shape of the foot (Fig 1) was cumbersome, therefore target vessels smaller than 1.8 mm could not be approached with the flat foot. Bad tissue capture was the most important reason for failure of the anastomotic device in our first series. The novel design (V-drive) applied in group II drastically improved our results. The modification of the foot shape and direction of needles penetrating the vessel wall led to improved tissue capture in group II. Coronary anastomoses with vessels of 1.5 mm inner diameter were successfully performed. The procedure was less time consuming, partly due to a simplified suture management. Significant reduction of bypass time as well as cross-clamp time in group II can also be contributed to the learning curve of the performing surgeon, because several steps of the anastomotic procedure were prepared before cardiopulmonary bypass.
The performance of the anastomotic device remains questionable in target vessels with extreme calcification or thin-walled vessels. In the majority of our applications, conventionally performed supplementary stitches were necessary to achieve hemostasis. Introduction of the device into the coronary vessel and correct angulation during release are the key elements of the procedure. Limitations for beating heart or endoscopic cases are evident, because tissue capture is highly dependent on visual control of the foot placement. It is important to mention that we did not preselect our study patients based on angiographic criteria or risk factors. Their target vessel quality is representative of the patients we operate on currently and in the future, and for whom anastomotic devices should be constructed.
Limitations of our study
We could not directly compare anastomotic quality of interrupted mechanical and conventionally handsewn anastomoses, because postoperative angiography was only performed in a minority of study patients. A comparison of the flow rates achieved using the device with conventionally sutured anastomoses would be misleading, because the coronary vessels grafted with the suturing device represent a positive selection.
We conclude that the Heartflo device for distal coronary anastomoses represents a promising step toward automated coronary anastomoses. Anastomotic suturing devices leave a minimum of endovascular material behind, an advantage with regard to intimal proliferation. Introduction of foreign material may reduce long-term patency of anastomoses created with other devices. Future developments should automate knot tying, or replace it. Our success rate in unselected patients undergoing coronary artery bypass grafting encourages the development of devices based on this prototype. The application through limited incisions, or in a totally endoscopic setting, seems not possible with the current model.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Wippermann, C. Konstas, M. Breuer, H. Kosmehl, T. Wahlers, and J. M. Albes Long-term effects in distal coronary anastomoses using different adhesives in a porcine off-pump model. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 325 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Klima, H. MacVaugh III, E. Bagaev, M. Maringka, S. Kirschner, J. Beilner, and A. Haverich Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting Circulation, September 14, 2004; 110(11_suppl_1): II-55 - II-60. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Carrel, L. Englberger, D. Keller, S. Windecker, B. Meier, and F. Eckstein Clinical and angiographic results after mechanical connection for distal anastomosis in coronary surgery J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1632 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Martens, M. Dietrich, C. Herzog, M. Doss, G. Schneider, A. Moritz, and G. Wimmer-Greinecker Automatic connector devices for proximal anastomoses do not decrease embolic debris compared with conventional anastomoses in CABG Eur J Cardiothorac Surg, June 1, 2004; 25(6): 993 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Carrel, F. S. Eckstein, L. Englberger, P. A. Berdat, and J. Schmidli Clinical experience with devices for facilitated anastomoses in coronary artery bypass surgery Ann. Thorac. Surg., March 1, 2004; 77(3): 1110 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. L. Suyker, M. P. Buijsrogge, P. T. W. Suyker, C. W. J. Verlaan, C. Borst, and P. F. Grundeman Stapled coronary anastomosis with minimal intraluminal artifact: The S2 Anastomotic System in the off-pump porcine model J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 498 - 503. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |